Know How to Manage Dyslipidemia in Patients Living With HIV
August 2019
Better antiretroviral therapy means more patients with HIV will face dyslipidemia and CV disease...instead of opportunistic infections.
HIV itself increases CV risk...possibly by triggering inflammatory mediators linked to atherosclerosis or activating platelets.
And early use of antiretrovirals is key...since uncontrolled HIV carries a higher risk of heart attack, stroke, heart failure, etc.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive